- Home
- BNC vs IMRX Comparison
BNC vs IMRX Comparison
Compare BNC & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNC | IMRX |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 286.8M | 232.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BNC | IMRX |
|---|---|---|
| Price | $7.02 | $6.19 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.20 |
| AVG Volume (30 Days) | 688.8K | ★ 819.3K |
| Earning Date | 12-23-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,027,431.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 27.46 | N/A |
| 52 Week Low | $4.65 | $1.10 |
| 52 Week High | $82.88 | $10.08 |
Technical Indicators
Market Signals| Indicator | BNC | IMRX |
|---|---|---|
| Relative Strength Index (RSI) | 51.68 | 40.95 |
| Support Level | $6.65 | $5.93 |
| Resistance Level | $7.72 | $6.54 |
| Average True Range (ATR) | 0.59 | 0.37 |
| MACD | 0.22 | -0.13 |
| Stochastic Oscillator | 72.94 | 15.30 |
Price Performance
Historical ComparisonAbout BNC CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.